Skip to main content
. 2020 Aug 25;105(12):e4417–e4429. doi: 10.1210/clinem/dgaa551

Table 3.

Hormonal Status

Patient Age (years) Mutation Hormonal levels
Basal FSH
IU/L [1.5-12]
FSH at the peak (after GnRH stimulation)
[1.5–2 × basal]
Basal LH
IUI/L [1.5-8.5]
LH at the peak (after GnRH stimulation)
[3-4 × basal]
Basal total testosterone nmol/L
[10.4-41.6]
Testosterone/LH (nMol / IU) PRL mIU/L
[86-324]
Leptin (µg/L)
1 22 BBS1: c.[479G>A];[479G>A], p.[Arg160Gln];[Arg160Gln] 2.42 4.65 4.71 29.3 16.3 3.46 239 21.2
2 25 BBS1: c.[1169T>G];[1169T>G], p.[Met390Arg];[Met390Arg] 2.67 5.02 2.94 20.8 not performed not performed 8.83
3 24 BBS1: c.[1169T>G];[1169T>G], p.[Met390Arg];[Met390Arg] 5.37 7.15 3.21 15.7 17.7 5.51 176 not performed
4 36 BBS1:
c.[382C>T];[382C>T], p.[Gln128*];[Gln128*]
not performed not performed not performed not performed not performed not performed not performed
5 24 BBS5: c.[413G>C];[413G>C], p.[Arg138Pro];[Arg138Pro] 3.26 5.94 3.64 20.6 13.8 3.79 134 12.6
6 35 BBS10: c.[271dup];[963T>G], p.[Cys91Leufs*5];[Tyr321*] 2.08 3.69 3.38 12.5 12.8 3.77 106 not performed
7 38 BBS1: c.[1169T>G]; [1214_1215ins[MT113356], p.[Met390Arg];[Ala406Glnfs*47]. 3.51 6.37 4.11 26.9 11.1 2.70 94.7 4.78
8* 22 BBS1: c.[1169T>G];[1169T>G], p.[Met390Arg];[Met390Arg] 0.85 not performed 0.71 not performed 18.7* Not applicable 295 19.8
9 26 BBS9:
c.[703-?_886+?del];[832C>T],
p.[Val235Phefs*6];[Arg278*]
1.56 3.16 1.66 12 6.9 4.15 normal 50.4
10 18 BBS3:
c.[535G>A];[535G>A], p.[Asp179Asn];[Asp179Asn]
2.84 8.46 3.57 51.8 8.6 2.4 72.1 not performed
11 39 BBS12: c.[1037T>C];[1037T>C], p.[Ile346Thr];[Ile346Thr] 9.41 20.5 7.02 43 11.1 1.58 209 not performed

*Patient 8 undergoing testosterone therapy